Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

MPS Venture

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 6
Average round size
info
The average size of a deal this fund participated in
$3M
Portfolio companies 5
Rounds per year 0.30
Lead investments 1
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.17
Key employees Soon

Areas of investment

  • Biotechnology
  • Mobile
  • Ad Network
  • Digital Entertainment
  • Mobile Advertising
Summary

In 2001 was created MPS Venture, which is appeared as VC. The fund was located in Europe if to be more exact in Italy. The leading representative office of defined VC is situated in the Firenze.

The usual cause for the fund is to invest in rounds with 2 partakers. Despite the MPS Venture, startups are often financed by INGENIUM Emilia Romagna, Fondamenta SGR. The meaningful sponsors for the fund in investment in the same round are Sviluppo Imprese Centro Italia, Zcube, MP Healthcare Venture Management. In the next rounds fund is usually obtained by Future Fifty, BlueGem Capital Partners.

The fund is constantly included in less than 2 deals per year. The important activity for fund was in 2008. Considering the real fund results, this VC is 3 percentage points less often commits exit comparing to other organizations. The usual things for fund are deals in the range of 5 - 10 millions dollars.

Besides, a startup needs to be aged 2-3 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Externautics, Neomobile, PharmEste. We can highlight the next thriving fund investment areas, such as Facility Management, Ad Network. For fund there is a match between the location of its establishment and the land of its numerous investments - Italy.

Read more

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Alecta -
Axess Ventures Israel, Tel Aviv, Tel Aviv District
Booking.com Amsterdam, Noord-Holland, The Netherlands
Boule Diagnostics Skane Lan, Spånga, Sweden
Buckthorn Partners -
CERN Pension Fund Geneva, Geneve, Switzerland
Chinese Anci Films & Television Fund Beijing, Beijing, China
Earnest Capital California, Jackson St Forest, United States
Green Highland Renewables Perth, Perth and Kinross, United Kingdom
Harry and David Medford, Oregon, United States
Live Oak Endeavors Charleston, South Carolina, United States
Low Carbon Seed Fund -
Metric Capital Partners England, London, United Kingdom
Mori Trust Japan, Tokyo
Polkuni -
TANSUN Chengguan District, China, Lhasa
Taylor Ventures California, Salinas, United States
Three Lakes Partners -
Unovis Asset Management New York, New York, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

PharmEste

Biopharma
Biotechnology
Therapeutics
$5M01 Jun 2011 Italy, Lombardy, Italy

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent MPS Venture?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 6
Average round size 3M
Rounds per year 0.30
Peak activity year 2008
Lead investments 1
Follow on index 0.17
Group Appearance index 0.83

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

PharmEste

Biopharma
Biotechnology
Therapeutics
$5M01 Jun 2011 Italy, Lombardy, Italy
Crunchbase icon

Content report

The following text will be sent to our editors: